Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies

References

• DawidczykCMKimCParkJHState-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicinesJ Control Release201418713314424874289
   PubMed Web of Science ®Google Scholar
• JainRKStylianopoulosTDelivering nanomedicine to solid tumorsNat Rev Clin Oncol2010765366420838415
   PubMed Web of Science ®Google Scholar
• BartlettDWSuHHildebrandtIJWeberWADavisMEImpact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imagingProc Natl Acad Sci U S A2007104155491555417875985
   PubMed Web of Science ®Google Scholar
• ChattopadhyayNFongeHCaiZRole of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivoMol Pharm2012982168217922734589
   PubMed Web of Science ®Google Scholar
• SannaVPalaNSechiMTargeted therapy using nanotechnology: focus on cancerInt J Nanomedicine2014946748324531078
   PubMed Web of Science ®Google Scholar
• RuoslahtiEBhatiaSNSailorMJTargeting of drugs and nanoparticles to tumorsJ Cell Biol201018875976820231381
   PubMed Web of Science ®Google Scholar
• KirpotinDBDrummondDCShaoYAntibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal modelsCancer Res2006666732674016818648
   PubMed Web of Science ®Google Scholar
• MatsumuraYMaedaHA new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancsCancer Res198646638763922946403
   PubMed Web of Science ®Google Scholar
• GuGXiaHHuQPEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapyBiomaterials20133419620823069707
   PubMed Web of Science ®Google Scholar
• GaoHYangZZhangSLigand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalizationSci Rep20133253423982586
   PubMed Web of Science ®Google Scholar
• ValenciaPMPridgenEMRheeMLangerRFarokhzadOCKarnikRMicrofluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapyACS Nano20137106711068024215426
   PubMed Web of Science ®Google Scholar
• PirolloKFChangEHDoes a targeting ligand influence nanoparticle tumor localization or uptake?Trends Biotechnol20082655255818722682
   PubMed Web of Science ®Google Scholar
• TheekBGremseFKunjachanSCharacterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imagingJ Control Release2014182838924631862
   PubMed Web of Science ®Google Scholar
• KunjachanSPolaRGremseFPassive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicinesNano Lett20141497298124422585
   PubMed Web of Science ®Google Scholar
• WangAZLangerRFarokhzadOCNanoparticle delivery of cancer drugsAnnu Rev Med20126318519821888516
   PubMed Web of Science ®Google Scholar
• CaiWGaoTHongHSunJApplications of gold nanoparticles in cancer nanotechnologyNanotechnol Sci Appl20081173224198458
   PubMedGoogle Scholar
• MezzarobaNZorzetSSeccoENew potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticlesPLoS One201389e7421624098639
   PubMed Web of Science ®Google Scholar
• MarínGHMansillaEMezzarobaNExploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphomaCurr Clin Pharmacol2010524625020925646
   PubMedGoogle Scholar
• RampazzoEBoschiFBonacchiSMulticolor core/shell silica nanoparticles for in vivo and ex vivo imagingNanoscale2012482483022159192
   PubMed Web of Science ®Google Scholar
• MacorPSeccoEMezzarobaNBispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in miceLeukemia201529240641424903480
   PubMedGoogle Scholar
• ZabucchiGSoranzoMRMenegazziREosinophil peroxidase deficiency: morphological and immunocytochemical studies of the eosinophil-specific granulesBlood199280290329101450416
   PubMedGoogle Scholar
• BiffiSDal MonegoSDullinCDendritic polyglycerolsulfate near infrared fluorescent (NIRF) dye conjugate for non-invasively monitoring of inflammation in an allergic asthma mouse modelPLoS One20138e5715023437332
   PubMedGoogle Scholar
• BiffiSPetrizzaLRampazzoEMultiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imagingRSC Adv201441827818285
   Google Scholar
• BiffiSGarrovoCMacorPIn vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imagingMol Imaging2008727228219123997
   PubMedGoogle Scholar
• FlorenaAMTripodoCIannittoEPorcasiRIngraoSFrancoVValue of bone marrow biopsy in the diagnosis of essential thrombocythemiaHaematologica20048991191915339673
   PubMed Web of Science ®Google Scholar
• StacchiniAAragnoMVallarioAMEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformationLeuk Res19992312713610071128
   PubMed Web of Science ®Google Scholar
• HallekMChesonBDCatovskyDGuidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelinesBlood20081115446545618216293
   PubMed Web of Science ®Google Scholar
• BertilaccioMTScielzoCSimonettiGA novel Rag2-/-gammac-/-- xenograft model of human CLLBlood20101151605160920018917
   PubMed Web of Science ®Google Scholar
• MombaertsPIacominiJJohnsonRSHerrupKTonegawaSPapaioannouVERAG-1-deficient mice have no mature B and T lymphocytesCell1992688698771547488
   PubMed Web of Science ®Google Scholar
• BancroftGJKellyJPMacrophage activation and innate resistance to infection in SCID miceImmunobiology19941914244317713556
   PubMedGoogle Scholar
• MansillaEMarinGHNuñezLThe lysosomotropic agent, hydroxychloroquine, delivered in a biodegradable nanoparticle system, overcomes drug resistance of B-chronic lymphocytic leukemia cells in vitroCancer Biother Radiopharm2010259710320187802
   PubMed Web of Science ®Google Scholar
• BraySJNotch signalling: a simple pathway becomes complexNat Rev Mol Cell Biol20067967868916921404
   PubMed Web of Science ®Google Scholar
• GatteiVBulianPDel PrincipeMIRelevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemiaBlood2008111286587317959854
   PubMed Web of Science ®Google Scholar